Shares of Inovio Pharmaceuticals Inc. (INO) are rising over 12% in pre-market today, after the company announced that it has received $71 million funding from the U.S. Department of Defense or DoD to support the large-scale manufacture of the company's proprietary CELLECTRA 3PSP smart device and the procurement of CELLECTRA 2000 devices, which are used to deliver INO-4800 directly into the skin.
from RTT - Before the Bell https://ift.tt/3dnIu2x
via IFTTT
No comments:
Post a Comment